Moderna’s vaccine isn’t the only one in the race. Pfizer is soon expected to announce if three of its even smaller-dose shots work for the littlest kids, months after the disappointing discovery that two doses weren’t quite strong enough. Whether it’s one company’s shots or both, ...
The emergence of Omicron has brought a shift in thinking about COVID-19 vaccines. Governments around the world are now promoting “booster shots” of mRNA vaccines (Moderna and Pfizer) as the best way to prevent hospitalization and death from the new variant. In fact, many now consider the ...
The U.S. Centers for Disease Control and Prevention also backed the FDA's authorization, clearing the way for the shots to be administered in children. The redesigned bivalent booster shots from both Moderna and Pfizer target the original version as well as the BA.4 and the ...
On April 15th, 2021, (@VPrasadMDMPH (Vinay Prasad)2021) I argued that, given the presence of alternatives (Pfizer and Moderna), that it was “game-over” for J&J in women less than 50 years old. The US should halt its use. Yet, the FDA released the pause and took no major act...
The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval.
The researchers found "low to absent" antibody neutralization of the variant from the regular regimens of all three vaccines - two shots of the Moderna or Pfizer/BioNTech vaccines or one of J&J's single-dose vaccine. But the blood from recent recipients of an ...
The FDA is looking to quickly approve Moderna’s coronavirus vaccine after it was unanimously backed by a panel of experts.
The FDA is set to convene its advisory committee of vaccine experts in April to deliberate how to arrange COVID-19 booster shots, including whether and when those boosters may be needed and for which populations, based on the available data and latest science on circulating or emerging virus ...
Buoyed by the success of its COVID-19 vaccine, Moderna has started a phase 1/2 trials of its mRNA-based shot for seasonal influenza, targeting four different flu strains. The first patents have now been enrolled into the study of the shot – codenamed m
Parents may find it confusing that Moderna is seeking to vaccinate the youngest children before it's cleared to vaccinate teens. While other countries already have allowed Moderna's shots to be used in children as young as 6, the U.S. has limited its vaccine to adults. ...